Chiara Dellepiane

8PUBLICATIONS
39CO-AUTHORS
Molecular targetsCancer geneticsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 26, 2025
Immune Checkpoint Inhibitors and Targeted Therapies in Early-Stage Non-Small-Cell Lung Cancer: State-of-the-Art and Future Perspectives.

Lucrezia Barcellini, Simone Nardin, Gianluca Sacco

|Jan 11, 2024
Molecular and Genetic Advances in Small Cell Lung Cancer Landscape: From Homogeneity to Diversity.

Lodovica Zullo, Filippo Gustavo Dall'Olio, Giovanni Rossi

|Mar 29, 2023
Prognostic Role of Soluble and Extracellular Vesicle-Associated PD-L1, B7-H3 and B7-H4 in Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors.

Carlo Genova, Roberta Tasso, Alessandra Rosa

|Oct 27, 2022
Immune Checkpoint Blockade: A Strategy to Unleash the Potential of Natural Killer Cells in the Anti-Cancer Therapy.

Melania Grottoli, Paolo Carrega, Lodovica Zullo

|Jul 27, 2022
A Circulating Risk Score, Based on Combined Expression of Exo-miR-130a-3p and Fibrinopeptide A, as Predictive Biomarker of Relapse in Resectable Non-Small Cell Lung Cancer Patients.

Silvia Marconi, Michela Croce, Giovanna Chiorino

|Apr 03, 2021
Novel Emerging Molecular Targets in Non-Small Cell Lung Cancer.

Sara Elena Rebuzzi, Lodovica Zullo, Giovanni Rossi

Pageof 2

Frequent Collaborators

7 joint publications

Simona Coco

6 joint publications

Marco Tagliamento

5 joint publications

Angela Alama

5 joint publications

Lodovica Zullo